NDC 83939-0022-01 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83939-0022
- Requested NDC
- 83939-0022-01
- Package NDCs from labels
- 83939-0022-1, 83939-0022-2, 83939-0022-3, 83939-0022-01
- Manufacturer
- VERITYRX, LLC
- Effective date
- 2025-10-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxybutynin Chloride - VERITYRX, LLC | VERITYRX, LLC | 2025-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83939-0022-1 | Oxybutynin Chloride | 1 in 1 POUCH | TABLET | 1 | 1 | |
| 83939-0022-2 | Oxybutynin Chloride | 1 in 1 POUCH | TABLET | 1 | 1 | |
| 83939-0022-2 | Oxybutynin Chloride | 50 in 1 BOX, UNIT-DOSE | TABLET | 50 | 1 | |
| 83939-0022-3 | Oxybutynin Chloride | 1 in 1 POUCH | TABLET | 1 | 1 | |
| 83939-0022-3 | Oxybutynin Chloride | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Proficient Rx LP | e3f0c249-8085-4979-823a-820e233a284f | 2022-06-01 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Proficient Rx LP | 88f08450-559e-4038-aad1-051e4ab283cf | 2022-06-01 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | Leading Pharma, LLC | b73b8338-8045-448f-87a6-3d289227d00e | 2022-02-14 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Lannett Company, Inc. | 615f3d95-197c-4fec-b81f-c26449c93c3b | 2020-02-21 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | e985e201-2fb3-4781-9790-a1a3db1ae2a1 | 2017-10-20 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 58136f28-70c1-4cf2-bcd7-858c5609431a | 2016-06-15 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.